Skip to main navigation Skip to search Skip to main content

CHIPP-PrEP: Cabotegravir-Hormone Interrogation of Pharmacokinetics/Pharmacodynamics for HIV Prevention in Cisgender and Transgender Persons

Project: Research

Project Details

StatusActive
Effective start/end date08/1/24 → 07/31/29

Funding

  • National Institute of Allergy & Infectious Disease: $371,866.00